BlackRock
HAE icon

BlackRock’s Haemonetics HAE Stock Holding History

BlackRock’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443M Buy
5,909,258
+289,279
+5% +$18.6M 0.01% 1308
2026
Q1 		$317M Sell
5,619,979
-200,975
-3% -$13.1M 0.01% 1406
2025
Q4 		$467M Sell
5,820,954
-199,724
-3% -$13.4M 0.01% 1156
2025
Q3 		$293M Sell
6,020,678
-344,100
-5% -$21.3M 0.01% 1429
2025
Q2 		$475M Buy
6,364,778
+7,614
+0.1% +$504K 0.01% 1089
2025
Q1 		$404M Buy
6,357,164
+197,260
+3% +$13.4M 0.01% 1166
2024
Q4 		$481M Sell
6,159,904
-54,472
-0.9% -$4.38M 0.01% 1110
2024
Q3 		$500M Buy
6,214,376
+255,263
+4% +$20.6M 0.01% 1075
2024
Q2 		$493M Sell
5,959,113
-25,268
-0.4% -$2.22M 0.01% 1016
2024
Q1 		$511M Sell
5,984,381
-55,636
-0.9% -$4.37M 0.01% 1020
2023
Q4 		$516M Buy
6,040,017
+258,268
+4% +$22.3M 0.01% 976
2023
Q3 		$518M Sell
5,781,749
-32,661
-0.6% -$2.92M 0.01% 872
2023
Q2 		$495M Buy
5,814,410
+38,873
+0.7% +$3.29M 0.01% 943
2023
Q1 		$478M Sell
5,775,537
-98,420
-2% -$7.97M 0.01% 943
2022
Q4 		$462M Buy
5,873,957
+334,707
+6% +$26.9M 0.01% 933
2022
Q3 		$410M Sell
5,539,250
-45,185
-0.8% -$3.24M 0.01% 940
2022
Q2 		$364M Sell
5,584,435
-367,290
-6% -$21.7M 0.01% 1086
2022
Q1 		$376M Sell
5,951,725
-740,621
-11% -$40.3M 0.01% 1184
2021
Q4 		$355M Sell
6,692,346
-298,196
-4% -$18.2M 0.01% 1290
2021
Q3 		$493M Buy
6,990,542
+1,011,239
+17% +$63.8M 0.01% 993
2021
Q2 		$398M Buy
5,979,303
+1,181,697
+25% +$83.6M 0.01% 1219
2021
Q1 		$533M Buy
4,797,606
+97,015
+2% +$12M 0.02% 950
2020
Q4 		$558M Sell
4,700,591
-191,334
-4% -$20.6M 0.02% 820
2020
Q3 		$427M Sell
4,891,925
-203,677
-4% -$17.8M 0.02% 842
2020
Q2 		$456M Sell
5,095,602
-877,406
-15% -$88.6M 0.02% 779
2020
Q1 		$595M Buy
5,973,008
+62,148
+1% +$6.74M 0.03% 538
2019
Q4 		$679M Buy
5,910,860
+46,733
+0.8% +$5.65M 0.03% 630
2019
Q3 		$740M Sell
5,864,127
-134,488
-2% -$17.1M 0.03% 542
2019
Q2 		$722M Sell
5,998,615
-386,622
-6% -$38M 0.03% 561
2019
Q1 		$559M Buy
6,385,237
+358,431
+6% +$32.6M 0.02% 666
2018
Q4 		$603M Buy
6,026,806
+92,894
+2% +$9.76M 0.03% 556
2018
Q3 		$680M Sell
5,933,912
-74,581
-1% -$7.72M 0.03% 586
2018
Q2 		$539M Sell
6,008,493
-916,433
-13% -$77.4M 0.02% 683
2018
Q1 		$507M Buy
6,924,926
+253,938
+4% +$17.4M 0.02% 697
2017
Q4 		$387M Buy
6,670,988
+225,160
+3% +$11.9M 0.02% 866
2017
Q3 		$289M Buy
6,445,828
+190,150
+3% +$7.9M 0.01% 1058
2017
Q2 		$247M Sell
6,255,678
-34,050
-0.5% -$1.4M 0.01% 1122
2017
Q1 		$255M Buy
6,289,728
+6,276,880
+48,855% +$245M 0.01% 1093
2016
Q4 		$517K Sell
12,848
-1,155
-8% -$43.5K ﹤0.01% 1694
2016
Q3 		$507K Buy
14,003
+712
+5% +$24.4K ﹤0.01% 1733
2016
Q2 		$385K Buy
13,291
+9,790
+280% +$296K ﹤0.01% 1774
2016
Q1 		$122K Buy
3,501
+1,950
+126% +$63K ﹤0.01% 1912
2015
Q4 		$50K Buy
1,551
+403
+35% +$13.1K ﹤0.01% 2058
2015
Q3 		$37K Sell
1,148
-3,507
-75% -$132K ﹤0.01% 2050
2015
Q2 		$193K Sell
4,655
-727
-14% -$30.6K ﹤0.01% 1681
2015
Q1 		$242K Sell
5,382
-422
-7% -$17.6K ﹤0.01% 1637
2014
Q4 		$217K Buy
5,804
+263
+5% +$9.63K ﹤0.01% 1496
2014
Q3 		$193K Sell
5,541
-10,518
-65% -$375K ﹤0.01% 1534
2014
Q2 		$567K Buy
16,059
+10,090
+169% +$337K ﹤0.01% 1309
2014
Q1 		$195K Buy
5,969
+4,316
+261% +$165K ﹤0.01% 1555
2013
Q4 		$70K Sell
1,653
-45
-3% -$1.85K ﹤0.01% 1826
2013
Q3 		$68K Buy
1,698
+42
+3% +$1.76K ﹤0.01% 1749
2013
Q2 		$69K Buy
+1,656
New +$67K ﹤0.01% 1761

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

BlackRock's HAE Position: Q2 2026 in Review

BlackRock increased its Haemonetics (HAE) stake by 5.1% in Q2 2026, buying an estimated $18.6M and bringing the position to 5,909,258 shares worth $443M. The position accounts for 0.01% of the portfolio, ranked #1308.

BlackRock first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $740M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • BlackRock held 5,909,258 shares of Haemonetics worth $443M as of Q2 2026.
  • BlackRock bought 289,279 Haemonetics shares in Q2 2026, an estimated $18.6M.
  • Haemonetics made up 0.01% of BlackRock's portfolio in Q2 2026, its #1308 holding.
  • BlackRock first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Haemonetics position peaked at $740M in Q3 2019.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.